top of page

Notification of regenerative medicine provision plan

Our hospital has obtained Type 2 and Type 3 regenerative medicine provision plan numbers.

Regenerative medicine can only be provided by licensed physicians at facilities that have been registered with and approved by the Ministry of Health, Labour and Welfare.
Our hospital is a medical facility that has submitted Type II and Type III regenerative medicine provision plans and obtained plan numbers in accordance with the Regenerative Medicine Act (Act on Ensuring the Safety of Regenerative Medicine, etc.).

Our hospital has been approved for a "Type II Regenerative Medicine Provision Plan".

● Chronic pain relief treatment using human autologous adipose tissue-derived mesenchymal stem cells

Our hospital has been approved for a "Type 3 Regenerative Medicine Provision Plan".

● Immunotherapy using αβT cells for cancer

● Immunotherapy using NK cells for cancer

● Immunotherapy using dendritic cells for cancer

● Immunotherapy using NKT cell-activated dendritic cells for cancer

● Immunotherapy using autoimmune cells for cancer treatment, prevention of recurrence and metastasis, and prevention of cancer development (6-combination immunotherapy)

Regenerative medicine for chronic pain

Autologous fat-derived stem cell drip therapy

This is regenerative medicine using the patient's own adipose-derived stem cells. We offer it as a new treatment option for chronic pain.

Learn more ›

Regenerative medicine related to cancer immunotherapy

αβ T cell therapy

This is a treatment method in which T lymphocytes, which have various functions necessary to attack cancer, are cultured outside the body, activated and proliferated, and then administered to the patient.

Learn more ›

WT1 dendritic cell vaccine therapy

This is a treatment method in which dendritic cells, which are immune cells that act as the command center for immune responses, take up cancer antigens that serve as markers for cancer cells and then return them to the body.​

Learn more ›
6 types of combined immunotherapy

This is a combination immunotherapy that combines six types of immunotherapy to provide a multifaceted approach to immune function tailored to the patient's condition.

Learn more ›

NK cell therapy

NK cells are a type of immune cell found in lymphocytes that have the innate ability to attack foreign substances. NK cells play an important role in early cancer treatment and defense against infectious diseases.

Learn more ›

NKT cell therapy

This is a treatment in which dendritic cells isolated from the patient's own blood are given the function of activating NKT cells and then administered intravenously.

Learn more ›
bottom of page